We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Embraces New Regulatory Approaches in Oncology, Cell Therapies and Across the Agency
Gottlieb Embraces New Regulatory Approaches in Oncology, Cell Therapies and Across the Agency
Commissioner Scott Gottlieb said there’s no better time for him to work at the FDA, with a slate of new agency authorities providing a “watershed opportunity” to shape the regulatory process.